Antithrombin Market
Antithrombin works by inhibiting certain enzymes involved in the blood clotting process, particularly thrombin (factor IIa) and activated factor X. These enzymes are essential for the formation of fibrin, a protein that forms the meshwork of a blood clot. By inhibiting thrombin and factor Xa, antithrombin helps regulate the clotting cascade and prevent the formation of excessive blood clots.
Antithrombin Market
E N D
Presentation Transcript
Antithrombin Market
Segmentation (Scope) By Application By Source & Dosage Form • Therapeutics • Human • Goat Milk • Research • Others • Diagnostics • Lyophilized • Others • Liquid © Coherent Market Insights. All Rights Reserved
Major Drivers • Surgery and Trauma: Surgical procedures and traumatic injuries can trigger a cascade of events that promote blood clotting. • Cancer and Chemotherapy: Cancer itself, as well as certain types of chemotherapy, can increase the risk of abnormal blood clotting. © Coherent Market Insights. All Rights Reserved
NORTH AMERICA ASIA PACIFIC Market Size US$ 577.4 million Market Size US$ 849.87 million CAGR 4.3%. CAGR 4.6%. © Coherent Market Insights. All Rights Reserved
Major Players Grifols Shire BDI Pharma rEVO Biologics Green Cross Corp CSL Limited GTC Biotherapeutics KedrionS.p.A Scripps Laboratories Inc. Lee Bisolutions © Coherent Market Insights. All Rights Reserved
Global Latex Medical Disposables Market (%)Analysis, By Product Type, 2023 30% ? ? ? ? Recombinant Antithrombin Plasma-derived Antithrombin Synthetic Antithrombin Others © Coherent Market Insights. All Rights Reserved